Latest Updates
-
7 Foods That May Boost Sperm Count in 90 Days, According to a Fertility Specialist -
10 Monsoon Diseases To Watch Out For And How To Prevent Them -
Rapper Santy Sharma’s YouTube Channel Deleted After Viral Remarks: What We Know -
Every Diet Works Until It Doesn't: Here's What Your Doctor Isn't Telling You About Long-Term Weight Loss -
Is Diabetes Only An "Old Age Disease"? What Young Indians Must Know -
FIFA World Cup 2026 Final: Spain's Golden Night, Mbappé's Record Boot, and Messi's Last Dance -
Naseeruddin Shah Birthday Special: How He Became the Face of Indian Parallel Cinema -
Arunima Sinha Birthday Special: The Woman Who Lost A Leg And Went On To Conquer Everest -
Alia Bhatt's Ethnic Outfits Stole Every Spotlight At Best Friend Akansha Ranjan Kapoor's Wedding Celebrations -
Jagannath Rath Yatra 2026: 10 Iconic Odia Delicacies Every Visitor Must Try In Puri
Serum Institute Seeks Emergency Use Authorisation For Its rBCG Tuberculosis Vaccine
The Serum Institute has applied to the Drugs Controller General of India seeking emergency use authorisation for its recombinant BCG (rBCG) vaccine for the prevention of tuberculosis, official sources said on Sunday. The EUA application was submitted on March 22 by Prakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII).

India's TB immunisation programme currently offers BCG vaccination at birth or as early as possible till one year of age.
SII already supplies life-saving vaccines to the government under the Universal Immunisation Programme, including Pneumococcal, IPV and Rotavirus, Singh mentioned in his letter.
The Pune-based firm is one of the companies which supply BCG vaccines to the government.
"Our government is committed to eliminating TB. The vision of TB-free India has been energised by the clarion call of the prime minister to end TB from our country by 2025, five years ahead of the Sustainable Development Goal of ending TB," Singh mentioned in his letter.
"Under the leadership of our CEO Adar C Poonawalla, our firm is committed to making available a safe, efficacious and high-quality world-class TUBERVAC-rBCG vaccine for newborns, children, adolescents and adults at an affordable price," an official source quoted Singh as having said in the application.
Recombinant BCG vaccines are manufactured through advanced technology that allows the insertion of foreign genes, or overexpression of native genes, into the BCG vaccine, an official explained.
The number of tuberculosis cases in India has seen a 19 per cent rise in 2021 over the previous year, and there has been an increase in the mortality rate due to all forms of TB between 2019 and 2020 by 11 per cent, according to the annual TB report released by Union Health Minister Mansukh Mandaviya on Thursday.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications